Status:
COMPLETED
geRman-widE mulTicenter Analysis of oRal Anticoagulation-associated intraCerebral hEmorrhage
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
OAC-ICH
Acute Management of OAC-ICH
Eligibility:
All Genders
18+ years
Brief Summary
Intracerebral hemorrhage \[ICH\] is the most feared complication of anticoagulant therapy \[OAC\]. Evidence regarding acute therapeutic interventions as well as secondary treatment approaches is still...
Detailed Description
Stroke in general is one of the leading causes for death and disability in the industrialized world. Cardiac thromboembolisms are a major contributor to ischemic infarction and the most frequent reaso...
Eligibility Criteria
Inclusion
- between 2006-2010 in one of the participating centers hospitalized patients with OAC-ICH
Exclusion
- secondary ICH other than OAC-ICH
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
1205 Patients enrolled
Trial Details
Trial ID
NCT01829581
Start Date
September 1 2011
End Date
January 1 2014
Last Update
February 26 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.